These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 5101998)

  • 21. Studies on the pressor response to aminoalkyl derivatives of theophylline, noradrenalinetheophylline and norephedrinetheophylline.
    Sakai K; Hashimoto K
    Arzneimittelforschung; 1972 Apr; 22(4):693-7. PubMed ID: 4403149
    [No Abstract]   [Full Text] [Related]  

  • 22. [Promotion of organ circulation by raubasine].
    Dietmann K
    Arzneimittelforschung; 1967 Aug; 17(8):969-75. PubMed ID: 5632071
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological studies on a new l,5-benzothiazepine derivative (CRD-401).
    Sato M; Nagao T; Yamaguchi I; Nakajima H; Kiyomoto A
    Arzneimittelforschung; 1971 Sep; 21(9):1338-43. PubMed ID: 5171789
    [No Abstract]   [Full Text] [Related]  

  • 24. [Coronary dilating properties of dihydroxyquinolenes with a xanthine substitution].
    Mercier J; Dessaigne S; Lespagnol A
    C R Seances Soc Biol Fil; 1973; 167(1):90-2. PubMed ID: 4804706
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological studies of 3-(3,3-diphenylpropylamino)-propyl-3',4',5'-trimethoxybenzoate (PF-26), a new coronary vasodilator.
    Hatano N; Sohji Y; Kawashima K; Kaneko H
    Arzneimittelforschung; 1971 Nov; 21(11):1628-33. PubMed ID: 5172070
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparison of the effect of ildamen and nonachlazin on the blood supply and activities of the heart].
    Kaverina NV; Chichkanov GG; Chumburidze VB
    Kardiologiia; 1978 Mar; 18(3):88-93. PubMed ID: 642245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening of substances with coronary vasodilator action].
    Lenke D
    Arzneimittelforschung; 1970 May; 20(5):655-67. PubMed ID: 5468054
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacology of 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-perhydro-1,4-diazepine (dilazep I.N.N.), a new coronary active substance].
    Lenke D; Brock N; Zechel HJ
    Arzneimittelforschung; 1972 Apr; 22(4):639-51. PubMed ID: 5068242
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
    Raff WK; Kosche F; Lochner W
    Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of oxyfedrine on cardiodynamics in halothane anesthesia (author's transl)].
    Sternitzke N; Schieffer H; Hoffmann W; Bette L
    MMW Munch Med Wochenschr; 1974 May; 116(20):1045-8. PubMed ID: 4211257
    [No Abstract]   [Full Text] [Related]  

  • 31. The acute hemodynamic effects of oxyfedrine.
    Cole JS; Kennedy JW
    J Clin Pharmacol New Drugs; 1971; 11(6):417-22. PubMed ID: 5211288
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antagonistic influencing of circulatory reactions following angiotensin and vasopressin in the anesthetized dog].
    Becker KH; Lorenz D
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):95. PubMed ID: 4306398
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of some new nor-camphane derivatives on the coronary flow.
    Sen P; Kapoor SL; Sanyal RK
    Indian J Physiol Pharmacol; 1969 Jul; 13(3):123-30. PubMed ID: 5362626
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)].
    Vater W; Kroneberg G; Hoffmeister F; Saller H; Meng K; Oberdorf A; Puls W; Schlossmann K; Stoepel K
    Arzneimittelforschung; 1972 Jan; 22(1):1-14. PubMed ID: 4622472
    [No Abstract]   [Full Text] [Related]  

  • 35. [Phenylbutylamino derivatives with a stimulating effect on the adrenergic beta-receptors and their action on the coronary circulation of dogs].
    Becker KH; Boltze KH; Lorenz D; Oberdörster G
    Arzneimittelforschung; 1966 Jul; 16(7):833-5. PubMed ID: 6014711
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of hexabendin on oxygen consumption, energeties and substrate metabolism of the heart. II. Studies with intravenous infusions].
    Kraupp O; Wolner E; Adler-Kastner L; Chirikdjian JJ; Ploszczanski B; Tuisl E
    Arzneimittelforschung; 1966 Jun; 16(6):697-705. PubMed ID: 6014578
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemodynamic and clinical studies of the coronary therapeutic agent oxyfedrin].
    Krosch H; Rikirsch P; Schäbitz J; Teichmann W
    Z Arztl Fortbild (Jena); 1972 Jun; 66(11):557-62. PubMed ID: 5072115
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of nitranol, nitropenton and nitrosorbid on the rate of the coronary blood flow and on the oxygen consumption of the myocardium].
    Buianov VV
    Farmakol Toksikol; 1967; 30(1):30-4. PubMed ID: 5594355
    [No Abstract]   [Full Text] [Related]  

  • 39. Enhancement of coronary vasodilator action of adenosne by 1,4-Bis-(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine (Dilazep I.N.N.).
    Sano N; Katsuki S; Kawada M
    Arzneimittelforschung; 1972 Oct; 22(10):1655-8. PubMed ID: 4677053
    [No Abstract]   [Full Text] [Related]  

  • 40. [Coronary arteries and myocardial perfusion in experimental acute vascular occlusion. Influence of pharmacological coronary dilatation].
    Hahn N; Felix R; Draznin N; Mayer R; Düx A; Sporbeck G
    Med Welt; 1971 Oct; 44():1738-40. PubMed ID: 5125834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.